EirGen launches Breast Cancer Drug

EirGen Pharma are pleased to announce the commercial launch of its early stage breast cancer drug Eir-012 in Hungary, Slovakia, Czech Republic and Portugal. Launches to other European countries will continue in the coming months. Managing Director and co-founder Patsy Carney said “ We are very pleased with the successful completion of the first molecule in our development portfolio. The company has a significant pipeline of drugs which are due for commercialisation in 2010 and beyond. We look forward to these launches contributing to further growth of the commercial manufacturing operations within the company”